Brief: Perimeter B-Series Oct With ImgAssist AI 2.0 Demonstrates Super-Superiority Compared To Standard-Of-Care In Pivotal Clinical Trial
20/11/2024 22:29
Nov 20 (Reuters) - Perimeter Medical Imaging AI Inc
PINK.V :
* PERIMETER B-SERIES OCT WITH IMGASSIST AI 2.0 DEMONSTRATES
SUPER-SUPERIORITY COMPARED TO STANDARD-OF-CARE IN PIVOTAL
CLINICAL TRIAL
* PERIMETER MEDICAL IMAGING AI INC - PRIMARY ENDPOINT MET
WITH
STATISTICALLY SIGNIFICANT REDUCTION IN RESIDUAL CANCER
* PERIMETER MEDICAL IMAGING AI INC - FDA PMA APPLICATION FOR
B-SERIES OCT EXPECTED EARLY 2025
Source text: ID:nPn7klgn8a
Further company coverage: PINK.V
Recent news on Perimeter Medical Imaging AI
See all newsCanada's Perimeter Medical Imaging AI Q2 loss narrows on lower expenses
Perimeter Medical Imaging Q1 net loss narrows
Brief: Perimeter Medical Imaging Ai Closes First Tranche Of Non-Brokered Private Placement
Canada's Perimeter Medical Imaging prelim Q4 revenue jumps 143%
Brief: Perimeter Schedules Fourth Quarter And Full Year 2025 Financial Results Conference Call For March 31St Provides Corporate Update